Spun off from Patients & Purpose in 2022, Science & Purpose aims to be for HCP audiences what its older sibling has long been for patient groups. The firm registered its presence early on, when launch client Gilead quickly expanded the scope of its engagement. S&P ended the year with 45 people under its roof and seems likely to expand that number — and its revenue sum — considerably before the year is out.
Thank you for accessing MM+M.
Create your free account or log in to continue reading this premium content.